K.R.R. Drugs & Intermediates Private Limited - Company Profile

It is a pharma private limited company based in Ameerpet, Hyderabad., Andhra Pradesh, India, established in 2002.
2002 Ameerpet, Hyderabad., Andhra Pradesh, India Active
Last Updated:
Access Report
About K.R.R. Drugs & Intermediates Private Limited

K.R.R. Drugs & Intermediates Private Limited, a active private limited company, was established on 30 January 2002 in Ameerpet, Hyderabad., Andhra Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239AP2002PTC038417. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.50 M.

Formerly known as Medeva Laboratories Private Limited. It upholds a compliant status. Employing 6 professional, Its leadership includes Subbarao Kattamuri (Director), Sushma Kattamuri (Director). Past directors included Subbarao Kattamuri, Venkateswara Reddy Dronadula, Vamsi Krishna Vanteru. It holds no open charges and ₹15.43 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at Flat No.406, Aditya Trade Centre,, Ameerpet, Hyderabad., Andhra Pradesh, 500038.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239AP2002PTC038417

  • Registration Number

    038417

  • Incorporation Date

    30 January 2002

  • Authorized Capital

    ₹2.50 Cr

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 Cr
  • Paid Up Capital ₹ 2.50 M
  • Company Age 24 Year, 15 Days
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 15.43 Cr
  • Revenue Growth **** %
  • Profit Growth **** -7.25%
  • Ebitda **** -12.67%
  • Net Worth -23.43%
  • Total Assets -6.02%
Company report

K.R.R. Drugs & Intermediates Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into K.R.R. Drugs & Intermediates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at K.R.R. Drugs & Intermediates Private Limited?
Current Directors
Name Designation Appointment Date Status
Subbarao Kattamuri Director 08 Jul 2015 Current
Sushma Kattamuri Director 13 Aug 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 04 Jun 2015 Past
Pramod Abcsdd Whole-Time Director 20 Dec 2023 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 17 Jun 2013 Past
Pramod Abcsdd Director 04 Jun 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of K.R.R. Drugs & Intermediates.

K.R.R. Drugs & Intermediates Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 7.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.43%.

K.R.R. Drugs & Intermediates revenue growth over time
K.R.R. Drugs & Intermediates profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -6.02%
*******
*******
*******
*******
Profit or Loss
*******
 -7.25%
*******
*******
*******
*******
Net Worth
*******
 -23.43%
*******
*******
*******
*******
EBITDA
*******
 -12.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of K.R.R. Drugs & Intermediates?

Unlock access to K.R.R. Drugs & Intermediates's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹154,318,000.00

Charges Breakdown by Lending Institutions
  • Syndicate Bank : 12.60 Cr
  • Central Bank Of India : 2.83 Cr
Latest Charge Details
Date Lender Amount Status
04 Oct 2014 Syndicate Bank ₹7.40 Cr Satisfied
01 Aug 2005 Syndicate Bank ₹2.75 Cr Satisfied
01 Aug 2005 Syndicate Bank ₹1.14 Cr Satisfied
08 Jun 2005 Syndicate Bank ₹1.31 Cr Satisfied
22 Mar 2004 Central Bank Of India ₹2.83 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at K.R.R. Drugs & Intermediates?

K.R.R. Drugs & Intermediates has a workforce of 6 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of K.R.R. Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K.R.R. Drugs & Intermediates's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on K.R.R. Drugs & Intermediates
Recent Activity within the Organization
  • Annual General Meeting

    K.R.R. Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Sushma Kattamuri was appointed as a Director was appointed as a Director on 13 Aug 2024 & has been associated with this company since 1 year 6 months . was completed.

  • Balance Sheet

    K.R.R. Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was recorded as a recent event.

  • Director Appointment

    Subbarao Kattamuri was appointed as a Director was appointed as a Director on 08 Jul 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.

  • Charges

    A charge registered on 04 Oct 2014 via Charge ID 10532574 with Syndicate Bank was fully satisfied on 02 Jun 2015. was recorded as a recent event.

  • Charges

    A charge registered on 01 Aug 2005 via Charge ID 90133288 with Syndicate Bank was fully satisfied on 08 Jan 2015. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of K.R.R. Drugs & Intermediates Private Limited?

The CIN of K.R.R. Drugs & Intermediates Private Limited is U24239AP2002PTC038417.

Where is K.R.R. Drugs & Intermediates Private Limited headquartered?

K.R.R. Drugs & Intermediates Private Limited is headquartered at Flat No.406, Aditya Trade Centre,, Ameerpet, Hyderabad., Andhra Pradesh, 500038.

When was K.R.R. Drugs & Intermediates Private Limited incorporated?

K.R.R. Drugs & Intermediates Private Limited was incorporated on 30 January 2002.

Who are the current directors of K.R.R. Drugs & Intermediates Private Limited?

The current directors of K.R.R. Drugs & Intermediates Private Limited are

What is the primary industry of K.R.R. Drugs & Intermediates Private Limited?

The primary industry of K.R.R. Drugs & Intermediates Private Limited is Manufacturing.

Is K.R.R. Drugs & Intermediates Private Limited a listed company?

K.R.R. Drugs & Intermediates Private Limited is unlisted.

What is the capital structure of K.R.R. Drugs & Intermediates Private Limited?

The authorized capital of K.R.R. Drugs & Intermediates Private Limited is ₹2.50 Cr, and the paid-up capital is ₹2.50 M.

What is the compliance status of K.R.R. Drugs & Intermediates Private Limited?

The compliance status of K.R.R. Drugs & Intermediates Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available